Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

"Correct use of inhaled corticosteroids in chronic obstructive pulmonary disease": a consensus document.

Archivos de bronconeumologia - 1 Apr 2015

Alcázar Navarrete Bernardino, Casanova Ciro, Miravitlles Marc, de Lucas Pilar, Riesco Juan Antonio, Rodríguez González-Moro José Miguel

Abstract excerpt

INTRODUCTION: Indications for inhaled corticosteroids (IC) in combination with long-acting bronchodilators (LABD) are well defined in clinical practice guidelines. However, there are some doubts about their efficacy and safety. The aim of this document is to establish an expert consensus to clari...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Inhalation
Share to Adrenal Cortex Hormones
Share to Adrenergic beta-Agonists

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Anti-Inflammatory Agents

Share to Bronchodilator Agents

Share to Drug Administration Schedule

Share to Muscarinic Antagonists

Share to Sputum

Source

Identifiers

PMID: 25540900
DOI: 10.1016/j.arbres.2014.11.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25540900-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

"Correct use of inhaled corticosteroids in chronic obstructive pulmonary disease": a consensus document.PMID 25540900Read ↗

Inhaled corticosteroids in asthma and chronic obstructive pulmonary disease combined phenotype: when to use and what to expect?Semantic proximity Read ↗

Applying the wisdom of stepping down inhaled corticosteroids in patients with COPD: a proposed algorithm for clinical practice.Semantic proximity Read ↗

Inhaled corticosteroids in COPD: the clinical evidence.Semantic proximity Read ↗

Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review.Semantic proximity Read ↗

Positioning new pharmacotherapies for COPD.Semantic proximity Read ↗

A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol.Semantic proximity Read ↗

Benefit-risk assessment of long-acting beta2-agonists in asthma.Semantic proximity Read ↗

Reduction of corticosteroid use in outpatient treatment of exacerbated COPD – Study protocol for a randomized, double-blind, non-inferiority study (The “RECUT”-Trial)Semantic proximity Read ↗

Investigating the rationale for COPD maintenance therapy prescription across Europe, findings from a multi-country studySemantic proximity Read ↗

Long- versus short-duration systemic corticosteroid regimens for acute exacerbations of COPD: A systematic review and meta-analysis of randomized trials and cohort studiesSemantic proximity Read ↗

Safety of long-acting beta-agonists in asthma: a review.Semantic proximity Read ↗

Efficacy and Safety of Modified Bushen Yiqi Formulas(MBYF) as Add-On To Formoterol and Budesonide in The Management of COPD: Study Protocol for A Multi-Center, Double-Blinded, Placebo-Controlled, Parallel-Group, Randomized Clinical TrialSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.